Fig. 6

Treatments applied in patients with bone limited (dark grey) and complex (light grey) CRMO. NSAID - non-steroidal anti-inflammatory drugs, DMARDs – disease modifying antirheumatic drugs, CS – corticosteroids, BIS – bisphosphonates, TNFi – tumour necrosis factor α inhibitors